Chemotherapy: Pemetrexed: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
3
Conditions studied
34
US states with sites
15
Countries
Phase breakdown
Phase 1 1
Phase 2 1
Conditions being studied
| Condition | Trials |
|---|---|
| Lung cancer | 2 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| NSCLC (Advanced Non-small Cell Lung Cancer) | 1 |
Recruiting trials involving Chemotherapy: Pemetrexed
- A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation
- A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Common questions
How many recruiting trials involve Chemotherapy: Pemetrexed?
2 recruiting trials across 3 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.